Association of plasma BDNF and MMP-9 levels with mild cognitive impairment: a matched case-control study
Abstract The prevalence of Alzheimer’s disease (AD) is on the rise globally, and everyone who develops AD eventually experiences mild cognitive impairment (MCI) first. Timely intervention at an early stage of the disease may mitigate disease progression. Recent studies indicate that BDNF and MMP-9 p...
Saved in:
| Main Authors: | Tingyu Zhang, Huili Si, Jiali Liao, Rulin Ma |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-12-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-024-81895-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of quantitative EEG biomarkers in Alzheimer’s disease and mild cognitive impairment: applications and insights
by: Yue Yuan, et al.
Published: (2025-04-01) -
Dynamic changes and prognostic value of glutathione S-transferase alpha in mild cognitive impairment and Alzheimer’s disease
by: Yangyang Tang, et al.
Published: (2024-12-01) -
The impact of the interaction between BDNF rs7103411 gene polymorphism and social activities on mild cognitive impairment in community-dwelling elderly adults
by: Zhenkun Tan, et al.
Published: (2025-01-01) -
Exploring the neuromagnetic signatures of cognitive decline from mild cognitive impairment to Alzheimer's disease dementiaResearch in context
by: Sinead Gaubert, et al.
Published: (2025-04-01) -
Neural mechanisms of non-pharmacological interventions in patients with mild cognitive impairment and Alzheimer's disease: An ALE meta-analysis
by: Ning Wang, et al.
Published: (2025-02-01)